Answers are grounded in this paper and cite their sources.
Advances in the management and care of patients with cystic fibrosis (CF) has led to the majority of patients surviving into adulthoodl. Whether this longevity has added 'quality years' to the lives of CF patients is a question which needs to be addressed. The aim of quality of life (QoL) measurement in cystic fibrosis should be to quantify and evaluate the impact of both the disease and its treatments on the wider aspects of the patient's life. Many patients appear to be living normal, independent lives regardless of the demanding treatment regimens and impaired lung function. Additionally, psychosocial functioning in CF patients has been reported to be similar to that of their healthy peers2, which suggests that these aspects of their QoL are good. Only a few studies, however, have directly measured QoL in CF and the interpretation of the data is largely problematic.
No takes yet. Share an insight, caveat, or question.
Abbott et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: